Press release
Non Hodgkin Lymphoma (NHL) Global Market Report 2025: Strong Growth Amid Advanced Treatments and Active Key Players
Non Hodgkin Lymphoma (NHL) Market Share
• The non Hodgkin lymphoma (NHL) market size has grown from $10.11 billion in 2024 to $11.01 billion in 2025 at a compound annual growth rate (CAGR) of 8.9%.
• The market size is expected to grow to $15.42 billion in 2029 at a CAGR of 8.8%.
• Growth drivers include advancements in diagnostics, chemotherapy, immunotherapy, clinical research and improved survival rates.
• In the forecast period, the growth can be attributed to a growing aging population, advancements in targeted therapies, immunotherapy innovations, precision medicine approaches, and increasing awareness and early detection.
What Is Driving The Growth In The Non Hodgkin Lymphoma (NHL) Global Market Report 2025?
The high prevalence of non-Hodgkin lymphoma is a driving factor for the growth of the non-Hodgkin lymphoma market. This cancer develops in the lymphatic system, a crucial part of our immune system. The condition's prevalence indicates its number in a particular population at any given time. Treatment, such as targeted management of cancer cells, is improving outcomes for patients. For example, in 2023, the American Cancer Society suggested that non-Hodgkin lymphoma accounts for 4% of all cancers. In the same year, the disease is set to affect around 80,550 Americans, including 44,880 males and 35,670 females. The observation that about 20,180 persons might die due to non-Hodgkin lymphoma also underlines the significance of the disease. Therefore, the high prevalence of non-Hodgkin lymphoma is driving the non-Hodgkin lymphoma market.
Request A Free Sample Copy: https://www.thebusinessresearchcompany.com/sample.aspx?id=10676&type=smp
Who Are the Key Players Driving Non Hodgkin Lymphoma (NHL) Global Market Report 2025 Growth?
• Bayer AG
• Teva Pharmaceutical Industries Ltd.
• F. Hoffmann La Roche Ltd.
• Merck & Co. Inc.
• Eli Lilly and Co.
• Novartis AG
• GlaxoSmithKline plc
• AbbVie Inc.
• AstraZeneca plc
• Takeda Pharmaceutical Company Limited
• Bristol Myers Squibb Co.
• Pfizer Inc.
• Celgene Corporation
• Sanofi S.A.
• Janssen Pharmaceuticals Inc.
• Johnson & Johnson
• Biogen Idec
• Boehringer Ingelheim GmbH
• Eisai Co. Ltd.
• Gilead Sciences
• Incyte Corporation
• Karyopharm Therapeutics
• Kite Pharma Inc.
• Kyowa Hakko Kirin Co. Ltd.
• MorphoSys AG
• Nordic Nanovector ASA
• Ono Pharmaceutical Co. Ltd.
• Seattle Genetics Inc.
• Spectrum Pharmaceuticals Inc.
What Are The Key Trends In The Non Hodgkin Lymphoma (NHL) Global Market Report 2025?
• Rise of biosimilars
• Integration of next-generation sequencing
• Adoption of car-t cell therapies
• Novel chemotherapy agents
• Real-world evidence and outcomes research
What Are The Segments Of The Global Non Hodgkin Lymphoma (NHL) Global Market Report 2025?
• By Type: B-Cell Lymphoma, T-Cell Lymphoma
• By Treatment: Surgery, Stem Cell Transplant, Chemotherapy, Immunotherapy, Targeted Therapy, Radiation Therapy
• By Route of Administration: Oral, Parenteral, Other Routes of Administration
• By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Other Distribution Channels
• By End-Users: Hospitals, Homecare, Specialty Centers, Other End Users
Which Region Leads The Non Hodgkin Lymphoma (NHL) Global Market Report 2025?
North America was the largest region in the non-Hodgkin lymphoma (NHL) market in 2024. Asia-Pacific is expected to be the fastest-growing region during the forecast period. The report covers various regions including Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.
Pre-book the Report for Swift Delivery: https://www.thebusinessresearchcompany.com/report/non-hodgkin-lymphoma-nhl-global-market-report
What Is Covered In The Non Hodgkin Lymphoma (NHL) Global Market Report 2025 Global Market Report?
- Market Size Analysis: Analyze the Non Hodgkin Lymphoma (NHL) Global Market Report 2025 size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the Non Hodgkin Lymphoma (NHL) Global Market Report 2025 for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall Non Hodgkin Lymphoma (NHL) Global Market Report 2025 growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the Non Hodgkin Lymphoma (NHL) Global Market Report 2025.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.
Request Customization for This Report: https://www.thebusinessresearchcompany.com/Customise?id=10676&type=smp
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Non Hodgkin Lymphoma (NHL) Global Market Report 2025: Strong Growth Amid Advanced Treatments and Active Key Players here
News-ID: 3831760 • Views: …
More Releases from The Business Research Company
Segment Evaluation and Major Growth Areas in the Personalized Testing and Supple …
The personalized testing and supplements sector is gaining remarkable traction, driven by advancements in technology and a rising consumer focus on tailored health solutions. As more individuals seek customized wellness options, this market is set to experience substantial expansion in the coming years. Here's an in-depth look at its current valuation, key players, significant trends, and the main market segments shaping its future.
Market Valuation and Expansion Forecast for Personalized Testing…
Top Players and Market Competition in the Skin Microbiome Industry
The skin microbiome market is emerging as a significant area of interest due to growing awareness about the critical role of skin health and innovative skincare technologies. As research advances and consumer preferences shift towards more natural and science-backed products, this market is set to undergo substantial growth. Let's explore the current market size, key players, driving factors, and upcoming trends shaping the skin microbiome industry.
Projected Expansion in the Skin…
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market …
The upadacitinib market is poised for significant expansion over the coming years, driven by advances in treatment options and increasing awareness of autoimmune diseases. This report delves into the market's current size, key drivers, major players, and the emerging trends shaping its future trajectory.
Steady Growth Expected in Upadacitinib Market Size Through 2029
The market for upadacitinib is projected to reach $2.54 billion by 2029, growing at a robust compound annual…
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Marke …
The Alzheimer's disease diagnostic sector is rapidly evolving as advancements in technology and healthcare infrastructure open new possibilities for early detection and personalized treatment. With rising awareness and innovative approaches, this market is poised for significant growth in the coming years. Let's explore the current market size, key drivers, leading companies, and emerging trends that are shaping this critical healthcare field.
Projected Market Size and Growth Trends in Alzheimer's Disease Diagnostics…
More Releases for Hodgkin
Hodgkin Lymphoma Treatment Market Poised to Reach USD 15.70 Bn by 2030 at 8.3% C …
Opening Paragraph
According to a new report by Maximize Market Research, the global Hodgkin Lymphoma Treatment Market was valued at USD 8.98 billion in 2023 and is projected to reach nearly USD 15.70 billion by 2030, growing at a CAGR of 8.3%.
Curious to peek inside? Grab your sample copy of this report now:https://www.maximizemarketresearch.com/request-sample/124690/
Key Highlights
Market Size & CAGR: Valued at USD 8.98 Bn in 2023, forecast to grow to USD 15.70…
High Prevalence Of Non-Hodgkin Lymphoma Fuels Market Growth: The Driving Engine …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Non Hodgkin Lymphoma (NHL) Market Size Growth Forecast: What to Expect by 2025?
The market size for non hodgkin lymphoma (NHL) has consistently seen robust growth in recent times. It is anticipated to expand from $10.11 billion in 2024 to $11.01 billion in 2025, with a compound annual growth…
Breakthrough Treatments for Non-Hodgkin Lymphoma
The Business Research Company recently released a comprehensive report on the Global Non Hodgkin Lymphoma (NHL) Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry.
According to The Business Research Company's, The non hodgkin…
Non Hodgkin Lymphoma Therapeutics Market & Pipeline Insight
The market for Non Hodgkin Lymphoma has significant unmet medical necessities in terms of demand for innovative drugs and novel technologies. This is one of the major factors behind the market witnessing rapid growth in Non Hodgkin Lymphoma segment. Past few decades have witnessed an increased level of activity with regards to development of new identification systems and drug mechanisms. In recent years, there have been an increasing number of…
Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) - Pipeline Review, H1 2017 | Market R …
Market Research Hub (MRH) has recently published a latest market study to its online portal, which is titled as “Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) - Pipeline Review, H1 2017” This study offers professional analysis of the current state of Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) Market.
Request Free Sample Report@ http://www.marketresearchhub.com/enquiry.php?type=S&repid=1049067
Market Research HUB’s latest Pharmaceutical and Healthcare disease pipeline guide Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) Pipeline Review, H1 2017, provides…
Non-Hodgkin Lymphoma - Heat Map and Analysis
ReportsWorldwide has announced the addition of a new report title Non-Hodgkin Lymphoma - Heat Map and Analysis to its growing collection of premium market research reports.
Non-Hodgkin lymphomas (NHL) are a heterogeneous group of malignancies that originate from lymphoid tissue, with varied clinical and biological features. There were an estimated 385,741 new cases of NHL and 199,630 deaths from NHL worldwide in 2012. NHLs are classified as either indolent (slow-growing)…
